AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 1 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 48 | -99.9% | 0.00% | -100.0% |
| Q2 2023 | $813 | -18.7% | 49,335 | +31935.7% | 0.00% | – |
| Q3 2021 | $1,000 | -75.0% | 154 | -78.2% | 0.00% | – |
| Q2 2021 | $4,000 | -96.9% | 708 | -95.0% | 0.00% | – |
| Q1 2021 | $130,000 | +36.8% | 14,303 | +0.6% | 0.00% | – |
| Q4 2020 | $95,000 | +33.8% | 14,215 | +1.4% | 0.00% | – |
| Q3 2020 | $71,000 | -78.4% | 14,015 | -65.5% | 0.00% | – |
| Q2 2020 | $328,000 | +195.5% | 40,615 | +189.1% | 0.00% | – |
| Q1 2020 | $111,000 | – | 14,049 | +200600.0% | 0.00% | – |
| Q1 2019 | $0 | – | 7 | -90.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 76 | -65.6% | 0.00% | – |
| Q3 2018 | $1,000 | -88.9% | 221 | -85.5% | 0.00% | – |
| Q2 2018 | $9,000 | -83.0% | 1,521 | -79.4% | 0.00% | – |
| Q1 2018 | $53,000 | -13.1% | 7,371 | -2.6% | 0.00% | – |
| Q4 2017 | $61,000 | +41.9% | 7,570 | +86.2% | 0.00% | – |
| Q3 2017 | $43,000 | +26.5% | 4,065 | +32.6% | 0.00% | – |
| Q2 2017 | $34,000 | – | 3,065 | +4615.4% | 0.00% | – |
| Q1 2017 | $0 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |